Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan · Delayed Price · Currency is TWD

47.90

+0.55 (1.16%)

Apr 20, 2026, 1:04 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Nutrition and Health Sector			2.17B	2.40B	2.54B	3.33B	3.93B
Nutrition and Health Sector Growth			-9.86%	-5.29%	-23.70%	-15.36%	14.36%
Western Medicine Segment			2.43B	2.33B	2.23B	2.06B	2.16B
Western Medicine Segment Growth			4.23%	4.38%	8.33%	-4.91%	4.33%
Total			4.59B	4.73B	4.77B	5.38B	6.09B
Total Growth			-2.93%	-0.77%	-11.45%	-11.65%	10.58%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			2.88B	2.79B	2.70B	2.61B	2.86B
Taiwan Growth			3.57%	3.30%	3.13%	-8.62%	6.28%
China			701.54M	1.04B	1.23B	1.92B	2.29B
China Growth			-32.24%	-15.51%	-36.16%	-16.11%	21.52%
Southeast Asia			992.73M	909.69M	845.25M	849.67M	944.09M
Southeast Asia Growth			9.13%	7.62%	-0.52%	-10.00%	0.94%
Other			12.74M	-	-	-	-
Total			4.59B	4.73B	4.77B	5.38B	6.09B
Total Growth			-2.93%	-0.77%	-11.45%	-11.65%	10.58%

Source: S&P Global Market Intelligence.